`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`UNITED STATES DEPARTMENT OF COMMERCE
`United States Patent and Trademark Office
`Address: COMMISSIONER FOR PATENTS
`PO. Box 1450
`Alexandria1 Virginia 22313-1450
`www.uspto.gov
`
`NOTICE OF ALLOWANCE AND FEE(S) DUE
`
`27777
`
`7590
`
`07/03/2013
`
`PHILIP S. JOHNSON
`JOHNSON & JOHNSON
`ONE JOHNSON & JOHNSON PLAZA
`
`NEW BRUNSWICK, NJ 08933-7003
`
`HUI, SAN MING R
`
`1629
`
`DATE MAILED: 07/03/2013
`
`13/034,340
`
`02/24/2011
`
`Alan H. Auerbach
`
`CGRSOOIUSCNTI
`
`1597
`
`TITLE OF INVENTION: Methods and Compositions for Treating Cancer
`
`
`
`
`
`APPLN. TYPE
`
`ENTITY STATUS
`
`ISSUE FEE DUE
`
`PUBLICATION FEE DUE
`
`PREV. PAID ISSUE FEE
`
`TOTAL FEE(S) DUE
`
`DATE DUE
`
`nonprovisional
`
`UNDISCOUNTED
`
`$ 1780
`
`$300
`
`$0
`
`$2080
`
`10/03/2013
`
`THE APPLICATION IDENTIFIED ABOVE HAS BEEN EXAMINED AND IS ALLOWED FOR ISSUANCE AS A PATENT.
`PROSECUTION ON THE MERITS IS CLOSED. THIS NOTICE OF ALLOWANCE IS NOT A GRANT OF PATENT RIGHTS.
`THIS APPLICATION IS SUBJECT TO WITHDRAWAL FROM ISSUE AT THE INITIATIVE OF THE OFFICE OR UPON
`PETITION BY THE APPLICANT. SEE 37 CFR 1.313 AND MPEP 1308.
`
`THE ISSUE FEE AND PUBLICATION FEE (IF REQUIRED) MUST BE PAID WITHIN THREE MONTHS FROM THE
`MAILING DATE OF THIS NOTICE OR THIS APPLICATION SHALL BE REGARDED AS ABANDONED.
`THIS
`STATUTORY PERIOD CANNOT BE EXTENDED.
`SEE 35 U.S.C. 151. THE ISSUE FEE DUE INDICATED ABOVE DOES
`NOT REFLECT A CREDIT FOR ANY PREVIOUSLY PAID ISSUE FEE IN THIS APPLICATION.
`IF AN ISSUE FEE HAS
`PREVIOUSLY BEEN PAID IN THIS APPLICATION (AS SHOWN ABOVE), THE RETURN OF PART B OF THIS FORM
`WILL BE CONSIDERED A REQUEST TO REAPPLY THE PREVIOUSLY PAID ISSUE FEE TOWARD THE ISSUE FEE NOW
`DUE.
`
`HOW TO REPLY TO THIS NOTICE:
`
`I. Review the ENTITY STATUS shown above. If the ENTITY STATUS is shown as SMALL or MICRO, verify whether entitlement to that
`entity status still applies.
`
`If the ENTITY STATUS is the same as shown above, pay the TOTAL FEE(S) DUE shown above.
`
`If the ENTITY STATUS is changed from that shown above, on PART B - FEE(S) TRANSMITTAL, complete section number 5 titled
`"Change in Entity Status (from status indicated above)".
`
`For purposes of this notice, small entity fees are 1/2 the amount of undiscounted fees, and micro entity fees are 1/2 the amount of small entity
`fees.
`
`II. PART B - FEE(S) TRANSMITTAL, or its equivalent, must be completed and returned to the United States Patent and Trademark Office
`(USPTO) with your ISSUE FEE and PUBLICATION FEE (if required). If you are charging the fee(s) to your deposit account, section "4b"
`of Part B - Fee(s) Transmittal should be completed and an extra copy of the form should be submitted. If an equivalent of Part B is filed, a
`request to reapply a previously paid issue fee must be clearly made, and delays in processing may occur due to the difficulty in recognizing
`the paper as an equivalent of Part B.
`
`III. All communications regarding this application must give the application number. Please direct all communications prior to issuance to
`Mail Stop ISSUE FEE unless advised to the contrary.
`
`IMPORTANT REMINDER: Utility patents issuing on applications filed on or after Dec. 12, 1980 may require payment of
`maintenance fees. It is patentee's responsibility to ensure timely payment of maintenance fees when due.
`
`PTOL—85 (Rev. 02/11)
`
`Page 1 of 4
`
`JANSSEN EXHIBIT 2164
`
`Wockhardt v. Janssen lPR2016-01582
`
`JANSSEN EXHIBIT 2164
`Wockhardt v. Janssen IPR2016-01582
`
`
`
`PART B - FEE(S) TRANSMITTAL
`
`Complete and send this form, together with applicable fee(s), to: Mail Mail Stop ISSUE FEE
`Commissioner for Patents
`PO. Box 1450
`Alexandria, Virginia 22313-1450
`or m (571)-273-2885
`
`through 5 should be completed where
`INSTRUCTIONS: This form should be used for transmitting the ISSUE FEE and PUBLICATION FEE (if required). Blocks 1
`ap ropriate. A11 further correspondence including the Patent, advance orders and notification of maintenance fees will be mailed to the current correspondence address as
`indicated unless corrected below or directed otherwise in Block 1, by (a) specifying a new correspondence address: and/or (b) indicating a separate "FEE ADDRESS" for
`maintenance fee notifications.
`
`CURRENT CORRESPONDENCE ADDRESS (Note: Use Block 1 for any change ofaddTESS)
`
`7590
`27777
`PHILIP S. JOHNSON
`JOHNSON & JOHNSON
`ONE JOHNSON & JOHNSON PLAZA
`
`07/03/2013
`
`NEW BRUNSWICK, NJ 08933-7003
`
`Note: A certificate of mailin can only be used for domestic mailings of the
`Fee(s) Transmittal. This certi icate cannot be used for any other accompanying
`apers. Each additional paper, such as an assignment or formal drawing, must
`have its own certificate of mailing or transmission.
`Certificate of Mailing or Transmission
`I hereby certify that this Fee(s) Transmittal is being deposited with the United
`States Postal Service with sufficient postage for first class mail in an envelope
`
`addressed to the Mail Stop ISSUE FEE address above, or being facsimile
`transmitted to the USPTO (571) 273—2885. on the date indicated below.
`
`(Date)
`
`(”mm ““1
`(Signature)
`
`APPLICATION NO.
`
`FILING DATE
`
`FIRST NAMED INVENTOR
`
`ATTORNEY DOCKET NO.
`
`CONFIRMATION NO.
`
`13/034,340
`
`02/24/2011
`
`Alan H. Auerbach
`
`CGR5001USCNT1
`
`1597
`
`TITLE OF INVENTION: Methods and Compositions for Treating Cancer
`
`APPLN. TYPE
`
`ENTITY STATUS
`
`ISSUE FEE DUE
`
`PUBLICATION FEE DUE
`
`PREV. PAID ISSUE FEE
`
`TOTAL FEE(S) DUE
`
`DATE DUE
`
`nonprovisional
`
`UNDISCOUNTED
`
`EXAMINER
`
`HUI, SAN MING R
`
`$1780
`
`ART UNIT
`
`1629
`
`$300
`
`$0
`
`$2080
`
`10/03/2013
`
`CLASS-SUB CLASS
`
`514— 170000
`
`1. Change of correspondence address or indication of "Fee Address" (37
`CFR 1.363).
`3 Chan e of correspondence address (or Change of Correspondence
`Address orm PTO/SB/ 122) attached.
`
`3 "Fee Address" indication (or "Fee Address" Indication form
`PTO/SB/47; Rev 03—02 or more recent) attached. Use of a Customer
`Number is required.
`
`
`
`2. For printing on the patent front page, list
`,
`.
`.
`1
`(1) the names of up to 3 reglstered patent attorneys
`or agents OR, alternatively,
`.
`.
`.
`(2) the name of a smgle flrm (haV1ng as a member a
`reglstered attorney or agent) and the names Of up to
`2 registered patent attorneys or agents. If no name Is
`listed, no name will be printed.
`
`
`
`
`
`2
`
`3
`
`3. ASSIGNEE NAME AND RESIDENCE DATA TO BE PRINTED ON THE PATENT (print or type)
`PLEASE NOTE: Unless an assignee is identified below, no assignee data will appear on the patent. If an assignee is identified below, the document has been filed for
`recordation as set forth in 37 CFR 3.11. Completion of this form is NOT a substitute for filing an assignment.
`(A) NAME OF ASSIGNEE
`(B) RESIDENCE: (CITY and STATE OR COUNTRY)
`
`Please check the appropriate assignee category or categories (will not be printed on the patent) : D Individual
`
`'3 Corporation or other private group entity '3 Government
`
`4a. The following fee(s) are submitted:
`3 Issue Fee
`
`
`
`] Publication Fee (No small entity discount permitted)
`3 Advance Order — # of Copies
`
`4b. Payment of Fee(s): (Please first reapply any previously paid issue fee shown above)
`3 A check is enclosed.
`
`3 Payment by credit card. Form PTO—2038 is attached.
`3 The Director is hereby authorized to charge the required fee(s), any deficiency, or credit any
`overpayment, to Deposit Account Number
`(enclose an extra copy of this form).
`
`
`
`PTOL—85 (Rev. 02/11)
`
`Page 2 of 4
`
`
`
`5. Change in Entity Status (from status indicated above)
`
` 3 Applicant certifying micro entity status. See 37 CFR 1.29
`
`3 Applicant asserting small entity status. See 37 CFR 1.27
`
`3 Applicant changing to regular undiscounted fee status.
`
`N_OTE: Absent a valid certification of Micro Entity Status (see form PTO/SB/ 15A and 15B) issue
`f—eepayment in the micro entity amount will not be accepted at the risk of application abandonment.
`N_O'E. If the application was previously under micro entity status checking this box will be taken
`tob—ea notification of loss of entitlement to 111ic1o entity status.
`N_O’E. Checking this box will be taken to be a notification of loss of entitlement to small or micro
`entity status as applicable
`
`
`
`NOTE: The Issue Fee and Publication Fee (if required) will not be accepted from anyone other than the applicant; a registered attorney or agent; or the assignee or other party in
`interest as shown b the records of the United States Patent and Trademark Office.
`
`Authorized Signature
`
`
`Date
`
`Typed or printed name
`
`Registration No.
`
`
`
`This collection of information1s required by 37 CFR 1.311. The information1s reqpired to obtain or retain a benefit by the public which1s to file (and by the USPTO to process)
`an application Confidentiality1s governedby 35 U.S.C. 122 and 37 CFR 1d14T 1s collection is estimated to take 12 minutes to complete including gathering, preparlng, and
`submitting the completed application form to the USPTO. Time will v
`eendin upon the individual case. Any comments on the amount of time you require to complete
`this form and/or su gestions for reducing this burden should be sent to
`edC ief In ormation Officer U.S. Patent and Trademark Office U.S. Department of Commerce P.O.
`Box 1450 Alexandgria Virg1nia 22313— 1450. DO NOT SEND PEES OR COMPLETED PORMS TO THlS ADDRESS. SEND T:O Commissioner for Patents P.O. Box 1450
`Alexandria, Virginia 22313g1450.
`Under the Paperwork Reduction Act of 1995 , no persons are required to respond to a collection of information unless it displays a valid OMB control number.
`
`PTOl.—85 (Rev. 02/] 1) Approved for use through 08/31/2013.
`
`0MB 0651—0033
`
`US. Patent and Trademark Office; US. DEPARTMENT OF COMMERCE
`
`Page 3 of 4
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`UNITED STATES DEPARTMENT OF COIVLVIERCE
`United States Patent and Trademark Office
`Address: COMMISSIONER FOR PATENTS
`PO. Box 1450
`Alexandria, Virginia 22313-1450
`www.uspto.gov
`
`APPLICATION NO.
`
`FILING DATE
`
`FIRST NAMED INVENTOR
`
`ATTORNEY DOCKET NO.
`
`CONFIRMATION NO.
`
`13/034,340
`
`02/24/2011
`
`Alan H. Allerbach
`
`CGR5001USCNT1
`
`1597
`
`PHILIP S. JOHNSON
`JOHNSON & JOHNSON
`ONE JOHNSON & JOHNSON PLAZA
`
`NEW BRUNSWICK, NJ 08933-7003
`
`HUI, SAN MING R
`
`1629
`
`DATE MAILED: 07/03/2013
`
`Determination of Patent Term Adjustment under 35 U.S.C. 154 (b)
`
`(application filed on or after May 29, 2000)
`
`The Patent Term Adjustment to date is 0 day(s). If the issue fee is paid on the date that is three months after the
`mailing date of this notice and the patent issues on the Tuesday before the date that is 28 weeks (siX and a half
`months) after the mailing date of this notice, the Patent Term Adjustment will be 0 day(s).
`
`If a Continued Prosecution Application (CPA) was filed in the above-identified application, the filing date that
`determines Patent Term Adjustment is the filing date of the most recent CPA.
`
`Applicant will be able to Obtain more detailed information by accessing the Patent Application Information Retrieval
`(PAIR) WEB site (http://pair.uspto.gov).
`
`Any questions regarding the Patent Term Extension or Adjustment determination should be directed to the Office of
`Patent Legal Administration at (571)-272-7702. Questions relating to issue and publication fee payments should be
`directed to the Customer Service Center of the Office of Patent Publication at 1—(888)—786—0101 or (571)—272—4200.
`
`PTOL—85 (Rev. 02/11)
`
`Page 4 Of 4
`
`
`
`Privacy Act Statement
`
`The Privacy Act of 1974 (PL. 93-579) requires that you be given certain information in connection with
`your submission of the attached form related to a patent application or patent. Accordingly, pursuant to
`the requirements of the Act, please be advised that: (1) the general authority for the collection of this
`information is 35 U.S.C. 2(b)(2); (2) furnishing of the information solicited is voluntary; and (3) the
`principal purpose for which the information is used by the US. Patent and Trademark Office is to process
`and/or examine your submission related to a patent application or patent. If you do not furnish the
`requested information, the US. Patent and Trademark Office may not be able to process and/or examine
`your submission, which may result in termination of proceedings or abandonment of the application or
`expiration of the patent.
`
`The information provided by you in this form will be subject to the following routine uses:
`
`1. The information on this form will be treated confidentially to the extent allowed under the Freedom
`of Information Act (5 U.S.C. 552) and the Privacy Act (5 U.S.C 552a). Records from this system of
`records may be disclosed to the Department of Justice to determine whether disclosure of these
`records is required by the Freedom of Information Act.
`A record from this system of records may be disclosed, as a routine use, in the course of presenting
`evidence to a court, magistrate, or administrative tribunal, including disclosures to opposing counsel
`in the course of settlement negotiations.
`. A record in this system of records may be disclosed, as a routine use, to a Member of Congress
`submitting a request involving an individual, to whom the record pertains, when the individual has
`requested assistance from the Member with respect to the subject matter of the record.
`A record in this system of records may be disclosed, as a routine use, to a contractor of the Agency
`having need for the information in order to perform a contract. Recipients of information shall be
`required to comply with the requirements of the Privacy Act of 1974, as amended, pursuant to 5
`U.S.C. 552a(m).
`. A record related to an International Application filed under the Patent Cooperation Treaty in this
`systcm of records may be discloscd, as a routine usc,
`to thc International Burcau of thc World
`Intellectual Property Organization, pursuant to the Patent Cooperation Treaty.
`. A record in this system of records may be disclosed, as a routine use, to another federal agency for
`purposes of National Security review (35 U.S.C. 181) and for review pursuant to the Atomic Energy
`Act (42 U.S.C. 218(c)).
`to the Administrator,
`. A record from this system of records may be disclosed, as a routine use,
`General Services, or his/her designee, during an inspection of records conducted by GSA as part of
`that agency's responsibility to recommend improvements in records management practices and
`programs, under authority of 44 U.S.C. 2904 and 2906. Such disclosure shall be made in accordance
`with the GSA regulations governing inspection of records for this purpose, and any other relevant
`(i.e., GSA or Commerce) directive. Such disclosure shall not be used to make determinations about
`individuals.
`
`. A record from this system of records may be disclosed, as a routine use, to the public after either
`publication of the application pursuant to 35 U.S.C. 122(b) or issuance of a patent pursuant to 35
`U.S.C. 151. Further, a record may be disclosed, subject to the limitations of 37 CFR 1.14, as a
`routine use, to the public if the record was filed in an application which became abandoned or in
`which the proceedings were terminated and which application is referenced by either a published
`application, an application open to public inspection or an issued patent.
`. A record from this system of records may be disclosed, as a routine use, to a Federal, State, or local
`law enforcement agency, if the USPTO becomes aware of a violation or potential violation of law or
`regulation.
`
`
`
`
`
`.
`.
`.
`Notice of Allowability
`
`Application No.
`13/034,340
`'
`3:?“er HUI
`
`Applicant(s)
`AUERBACH ET AL.
`'
`AIA (Firstlnventor to
`f‘gggn't
`File) status
`No
`
`-- The MAILING DA TE of this communication appears on the cover sheet with the correspondence address--
`All claims being allowable, PROSECUTION ON THE MERITS IS (OR REMAINS) CLOSED in this application.
`If not included
`herewith (or previously mailed), a Notice of Allowance (PTOL-85) or other appropriate communication will be mailed in due course. THIS
`NOTICE OF ALLOWABILITY IS NOT A GRANT OF PATENT RIGHTS. This application is subject to withdrawal from issue at the initiative
`of the Office or upon petition by the applicant. See 37 CFR 1.313 and MPEP 1308.
`
`1.
`
`This communication is responsive to 6/4/2013.
`
`[I A declaration(s)/affidavit(s) under 37 CFR 1.130(b) was/were filed on
`
`2. [I An election was made by the applicant in response to a restriction requirement set forth during the interview on
`requirement and election have been incorporated into this action.
`
`; the restriction
`
`3. E The allowed claim(s) is/are 37—56. As a result of the allowed claim(s), you may be eligible to benefit from the Patent Prosecution
`I».
`Highway program at a participating intellectual property office for the corresponding application. For more information, please see
`
`hit? :/'/www.us'to. ov/ atents/init events/r
`I1/index.‘s' or send an inquiry to PPeredback mus today.
`
`4. El Acknowledgment is made of a claim for foreign priority under 35 U.S.C. § 119(a)—(d) or (f).
`
`Certified copies:
`
`a) [I All
`
`b) [I Some
`
`*c) D None of the:
`
`1. El Certified copies of the priority documents have been received.
`
`2. I] Certified copies of the priority documents have been received in Application No.
`
`
`
`3. El Copies of the certified copies of the priority documents have been received in this national stage application from the
`International Bureau (PCT Rule 17.2(a)).
`
`* Certified copies not received:
`
`Applicant has THREE MONTHS FROM THE “MAILING DATE” of this communication to file a reply complying with the requirements
`noted below. Failure to timely comply will result in ABANDONMENT of this application.
`THIS THREE-MONTH PERIOD IS NOT EXTENDABLE.
`
`5. D CORRECTED DRAWINGS ( as “replacement sheets”) must be submitted.
`
`El
`
`including changes required by the attached Examiner’s Amendment / Comment or in the Office action of
`Paper No./Mai| Date
`.
`Identifying indicia such as the application number (see 37 CFR 1.84(c)) should be written on the drawings in the from (not the back) of
`each sheet. Replacement sheet(s) should be labeled as such in the header according to 37 CFR 1.121(d).
`
`6. El DEPOSIT OF and/or INFORMATION about the deposit of BIOLOGICAL MATERIAL must be submitted. Note the
`attached Examiner’s comment regarding REQUIREMENT FOR THE DEPOSIT OF BIOLOGICAL MATERIAL.
`
`Attachment(s)
`1. I] Notice of References Cited (PTO-892)
`
`2. El Information Disclosure Statements (PTO/SB/08),
`Paper No./Mai| Date
`3. I:I Examiner‘s Comment Regarding Requirement for Deposit
`of Biological Material
`4. D Interview Summary (PTO-413),
`Paper No./Mai| Date
`
`/San-ming Hui/
`Primary Examiner, Art Unit 1629
`
`5. El Examiner's Amendment/Comment
`
`6. IX Examiner's Statement of Reasons for Allowance
`
`7. El Other
`
`.
`
`
`
`
`US. Patent and Trademark Office
`
`PTOL-37 (Rev. 05-13)
`
`Notice of Allowability
`
`Part of Paper No./Mai| Date 20130628
`
`
`
`Application/Control Number: 13/034,340
`
`Page 2
`
`Art Unit: 1629
`
`DETAILED ACTION
`
`Applicant’s response filed June 4, 2013 has been entered.
`
`Claims 37-56 are pending.
`
`The following is an examiner’s statement of reasons for allowance: The unexpected
`
`commercial success of the launch of the drug obviates the rejection under 35 USC
`
`103(a).
`
`Any comments considered necessary by applicant must be submitted no later
`
`than the payment of the issue fee and, to avoid processing delays, should preferably
`
`accompany the issue fee. Such submissions should be clearly labeled “Comments on
`
`Statement of Reasons for Allowance.”
`
`Claims 37-56 are allowed.
`
`Any inquiry concerning this communication or earlier communications from the
`
`examiner should be directed to SAN-MING HUI whose telephone number is (571)272-
`
`0626. The examiner can normally be reached on Mon - Fri from 9:00 to 5:00.
`
`If attempts to reach the examiner by telephone are unsuccessful, the examiner’s
`
`supervisor, Melenie McCormick can be reached on (571) 272-8037. The fax phone
`
`number for the organization where this application or proceeding is assigned is 571 -
`
`273-8300.
`
`
`
`Application/Control Number: 13/034,340
`
`Page 3
`
`Art Unit: 1629
`
`Information regarding the status of an application may be obtained from the
`
`Patent Application Information Retrieval (PAIR) system. Status information for
`
`published applications may be obtained from either Private PAIR or Public PAIR.
`
`Status information for unpublished applications is available through Private PAIR only.
`
`For more information about the PAIR system, see http://pair-direct.uspto.gov. Should
`
`you have questions on access to the Private PAIR system, contact the Electronic
`
`Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a
`
`USPTO Customer Service Representative or access to the automated information
`
`system, call 800-786-9199 (IN USA OR CANADA) or 571-272—1000.
`
`San-ming Hui
`Primary Examiner
`Art Unit 1629
`
`/San-ming Hui/
`Primary Examiner, Art Unit 1629
`
`
`
`Issue Classification 13034340
`
`AUERBACH ET AL.
`
`Application/Control No.
`
`Applicant(s)/Patent Under Reexamination
`
`SAN-MING HUI
`
`1629
`
`CPC Combination Sets
`
`1 U
`
`(Assistant Examiner)
`/SAN-M|NG HUI/
`Primary Examiner.Art Unit 1629
`
`(Primary Examiner)
`.S. Patent and Trademark Office
`
`06/28/2013
`
`(Date)
`
`Total Claims Allowed:
`
`20
`
`O.G. Print Claim(s)
`
`O.G. Print Figure
`
`1
`
`Part of Paper No. 20130628
`
`
`
`Issue Classification 13034340
`
`AUERBACH ET AL.
`
`Application/Control No.
`
`Applicant(s)/Patent Under Reexamination
`
`SAN-MING HUI
`
`1629
`
`US ORIGINAL CLASSIFICATION
`
`INTERNATIONAL CLASSIFICATION
`
`CLASS
`
`SUBCLASS
`
`170
`
`CLAIMED
`31 / 56 (2006.01.01)
`
`NON-CLAIMED
`
`CROSS REFERENCE(S)
`
`SUBCLASS (ONE SUBCLASS PER BLOCK)
`
`
`
`
`
`O.G. Print Figure (Primary Examiner)
`
`Total Claims Allowed:
`
`20
`
`06/28/2013
`
`O.G. Print Claim(s)
`
`(Date)
`
`1
`
`1
`Part of Paper No. 20130628
`
`(Assistant Examiner)
`/SAN-M|NG HUI/
`Primary Examiner.Art Unit 1629
`
`U.S. Patent and Trademark Office
`
`
`
`Issue Classification 13034340
`
`AUERBACH ET AL.
`
`Application/Control No.
`
`Applicant(s)/Patent Under Reexamination
`
`SAN-MING HUI
`
`1629
`
`IX
`
`Claims renumbered in the same order as presented by applicant
`
`El
`
`El
`
`T.D
`
`El
`
`
`
`
`
`
`
`
`
`
`
`Original
`Final
`OrIgInal
`Final
`Original
`Final
`Original
`Final
`Original
`Final
`Original
`Final
`Original
`Final
`Original
`Final
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`1
`
`Total Claims Allowed:
`
`20
`
`06/28/2013
`
`O.G. Print Claim(s)
`
`O.G. Print Figure
`
`(Date)
`
`1
`
`Part of Paper No. 20130628
`
`(Assistant Examiner)
`/SAN-M|NG HUI/
`Primary Examiner.Art Unit 1629
`
`(Primary Examiner)
`U.S. Palenl and Trademark Office
`
`
`
`
`
`Application/Control No.
`
`Search NOTES
`
`13034340
`
`Applicant(s)/Patent Under
`Reexamination
`
`AUERBACH ET AL.
`
`
`
`
`
`
`
`Examiner
`
`SAN-MING HUI
`
`
`
`Art Unit
`
`1628
`
`CPC- SEARCHED
`
`
`
`CPC COMBINATION SETS - SEARCHED
`
`US CLASSIFICATION SEARCHED
`
`514
`
`
`
`
`Class
`Subclass
`Date
`Examiner
`1/27/11
`SH
`9/5/12
`2/25/13
`6/28/13
`
`170,182
`170, 182
`170,182
`—170,182
`
`SEARCH NOTES
`
`Search Notes mm
`EAST search and inventor search in PALM
`EAST search and inventor search in PALM
`EAST search and inventor search in PALM
`EAST search and inventor search in PALM
`
`INTERFERENCE SEARCH
`
`US Class/
`CPC S mbol
`
`US Subclass / CPC Group
`
`170,182
`
`6/28/13
`
`
`
`US Patent and Trademark Office
`
`Part of Paper No.
`
`1 20130628
`
`
`
`EAST Search History
`
`EAST Search History
`
`EAST Search History (Prior Art)
`
`Default
`
`Eabiraterone
`
`EUS—PGPLB; USPAT; EPO; JPO;
`EDERWENT; IBMiTDB
`
`Eprdnisone
`5
`
`EUS—PGPLB; USPAT; EPO; JPO;
`DERWENT;
`|BM_TI)B
`
`Eprednisone
`
`US—PGPLB; USPAT'
`
`
`
`
`
`
`
`prostate
`
`EL1 and L4
`
`L1 same L4
`
`514/170.cc|s.
`
`514/182.cc|s.
`
`cancer
`
`EL1 and L9
`
`L1 same L9
`
`"9320097".pn.
`
`"9509178".pn.
`
`E"9509178".pn.§
`EandLQ
`
`.
`
`.
`
`.
`
`E2013/06/28§
`1:08
`:
`
`6/ 28/ 2013 12:03:30 PM
`
`C:\ Users\ shui\ Documents\ EAST\ Workspaces\ 1 3-034340.wsp
`
`file:///CIlUsers/shui/Documents/e—Red%20F01der/13034340/EASTSenrchHixmrv 12024240 AccessibleVeminn htmf6/78/7012 17/0242 PM]
`
`